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reported by Karpathiou et al.  [1] are very encouraging. 
The diagnostic accuracy of frozen sections critically de-
pends on the organ site, with the highest number of di-
agnoses deferred until final histology reported for speci-
mens from the lung/pleural/mediastinal region (13%) 
 [2] . The type of malignancy is also of importance, as ex-
emplified by the difficulties that the discrimination of 
malignant pleural mesothelioma (MPM) from reactive 
changes may pose to capture invasive growth, even on 
final histological examination, and adequate sampling 
may be of utmost importance in this context  [3] . Accord-
ingly, in a series of 20 medical thoracoscopy specimens, 
only 2 out of 6 MPMs were called malignant during in-
traoperative examination  [4] . In the present study, the 
rate of false negative and deferred diagnoses was overall 
significantly lower, but also highest (5/31, 16.1%) in the 
MPM group. The superior accuracy could be due to pre-
sumably different thoracoscopic techniques applied and 
ultimately also specimen dimensions. Although pure bi-
opsy size did not affect diagnostic accuracy of frozen sec-
tion examination, biopsy depth – important for judging 
invasive growth – was not examined, and Karpathiou et 
al.  [1] did not specify the method of biopsy acquisition. 
As semi-rigid techniques employing smaller flexible for-
ceps become more widely available, smaller biopsy size 
and reduced depth may become a relevant issue affecting 
diagnostic performance of frozen sections, warranting 
further studies  [5, 6] .
 An unclear pleural effusion is a frequently encoun-
tered problem and thoracoscopic pleural biopsies may be 
necessary to establish the diagnosis. Also, pleurodesis – 
most commonly with talc – is part of the state-of-the-art 
management of malignant pleural effusions in selected 
patients and should ideally be performed concomitantly 
with the diagnostic intervention. In the current issue of 
 Respiration , Karpathiou et al.  [1] address the clinically 
relevant question how accurately frozen sections of tho-
racoscopic pleural biopsies establish the diagnosis of ma-
lignancy versus the absence thereof. Following the evalu-
ation of 156 consecutive specimens, a diagnosis was ren-
dered in 149 (95.5%) cases on frozen section examination 
(97 malignant, 52 benign), and 7 cases (4.5%) were incon-
clusive. When compared with the final diagnosis after 
conventional formalin fixation, paraffin embedding, he-
matoxylin and eosin staining, and the application of ad-
ditional auxiliary techniques if needed, 144 out of 156 
(92.3%) diagnoses were concordant, but 5 (3.2%) were 
discrepant, with 1 false positive and 4 false negative calls. 
The authors derive a sensitivity of 96.26%, a specificity of 
97.87%, a negative predictive value of 92%, and a positive 
predictive value of 99.04%. Therefore, the most salient 
finding from this study is that diagnosis of malignancy on 
frozen sections is feasible, reliable, and may be followed 
by immediate pleurodesis during the same procedure.
 The accuracy of pleural frozen section examination 
has been assessed in only few reports so far, and the data 
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 Also, in subsequent studies it would be desirable to 
provide the diagnostic criteria for malignancy present in 
the individual cases assessed and their impact on diagno-
sis. Was infiltrative growth a sine qua non for diagnosing 
malignancy on frozen sections? And if not, in how many 
cases was it present? Loss of BAP1 expression assessed by 
immunohistochemistry and p16 deletion assessed by flu-
orescence in situ hybridization have recently proven 
valuable specific markers confirming malignancy in me-
sothelial lesions, enabling definite diagnosis, even in cy-
tology specimens  [7, 8] . Staining for cytokeratin can high-
light invasive growth, and other immunohistochemical 
markers help to diagnose carcinoma infiltrates  [3] . This 
may thus have an impact on the necessity of future diag-
nostic approaches with pleural frozen sections. Ultimate-
ly, the added value of pleural frozen sections needs to be 
placed in the context of the ever-evolving landscape of 
available auxiliary techniques that may be necessary to 
reach the final diagnosis.
 Although the study by Karpathiou and colleagues is 
retrospective in nature, with inherent limitations, it sheds 
light on an important domain and clinically relevant 
question, providing encouraging data for both clinicians 
and pathologists.
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